Bone marrow and circulating stem/progenitor cells for regenerative cardiovascular therapy (Q37783801)

23 August 2017

title

Bone marrow and circulating stem/progenitor cells for regenerative cardiovascular therapy (English)

1 reference

23 August 2017

1 reference

1 reference

Mohamad Amer Alaiti

1 reference

23 August 2017

Masakazu Ishikawa

series ordinal

1 reference

23 August 2017

Marco A Costa

series ordinal

1 reference

23 August 2017

publication date

1 September 2010

1 reference

23 August 2017

published in

Translational Research

1 reference

23 August 2017

volume

156

1 reference

23 August 2017

1 reference

23 August 2017

page(s)

112-129

1 reference

Global burden of cardiovascular diseases: part I: general considerations, the epidemiologic transition, risk factors, and impact of urbanization

23 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2010.06.008

Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2010.06.008

Isolation of putative progenitor endothelial cells for angiogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2010.06.008

Endothelial progenitor cells: identity defined?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2010.06.008

Unresolved questions, changing definitions, and novel paradigms for defining endothelial progenitor cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2010.06.008

Increased circulating hematopoietic and endothelial progenitor cells in the early phase of acute myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2010.06.008

Mobilization of endothelial progenitor cells in patients with acute myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2010.06.008

Mobilization of bone marrow-derived stem cells after myocardial infarction and left ventricular function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2010.06.008

CD34 + and Endothelial Progenitor Cells in Patients With Various Degrees of Congestive Heart Failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2010.06.008

Circulating endothelial progenitor cells in congestive heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2010.06.008

Circulating endothelial progenitor cells in patients with cardiac syndrome X.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2010.06.008

Increase in circulating endothelial progenitor cells by statin therapy in patients with stable coronary artery disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2010.06.008

Effect of intensive vs standard statin therapy on endothelial progenitor cells and left ventricular function in patients with acute myocardial infarction: Statins for regeneration after acute myocardial infarction and PCI (STRAP) trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2010.06.008

Erythropoietin regulates endothelial progenitor cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2010.06.008

Estrogen increases bone marrow-derived endothelial progenitor cell production and diminishes neointima formation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2010.06.008

SDF-1 genotype influences insulin-dependent mobilization of adult progenitor cells in type 2 diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2010.06.008

Age-dependent impairment of endothelial progenitor cells is corrected by growth-hormone-mediated increase of insulin-like growth-factor-1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2010.06.008

Growth hormone treatment improves markers of systemic nitric oxide bioavailability via insulin-like growth factor-I

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2010.06.008

Nitroglycerin attenuates human endothelial progenitor cell differentiation, function, and survival.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2010.06.008

Circulating endothelial progenitor cells and cardiovascular outcomes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2010.06.008

Exercise acutely increases circulating endothelial progenitor cells and monocyte-/macrophage-derived angiogenic cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2010.06.008

Physical training increases endothelial progenitor cells, inhibits neointima formation, and enhances angiogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2010.06.008

Vascular endothelial function and circulating endothelial progenitor cells in patients with cardiac syndrome X

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2010.06.008

Running exercise of different duration and intensity: effect on endothelial progenitor cells in healthy subjects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2010.06.008

Increase of circulating endothelial progenitor cells in patients with coronary artery disease after exercise-induced ischemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2010.06.008

Selective functional exhaustion of hematopoietic progenitor cells in the bone marrow of patients with postinfarction heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2010.06.008

Reduced number of circulating endothelial progenitors and HOXA9 expression in CD34+ cells of hypertensive patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2010.06.008

Circulating CD34+ cells, metabolic syndrome, and cardiovascular risk

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2010.06.008

Reduced number of circulating endothelial progenitor cells predicts future cardiovascular events: proof of concept for the clinical importance of endogenous vascular repair

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2010.06.008

Reduced endothelial progenitor cells in European and South Asian men with atherosclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2010.06.008

Decrease in circulating endothelial progenitor cells in patients with stable coronary artery disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2010.06.008

Glucose tolerance is negatively associated with circulating progenitor cell levels

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2010.06.008

Peripheral blood CD34+KDR+ endothelial progenitor cells are determinants of subclinical atherosclerosis in a middle-aged general population.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2010.06.008

Number and Function of Endothelial Progenitor Cells as a Marker of Severity for Diabetic Vasculopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2010.06.008

Circulating endothelial progenitor cells are reduced in peripheral vascular complications of type 2 diabetes mellitus.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2010.06.008

Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2010.06.008

Smoking cessation rapidly increases circulating progenitor cells in peripheral blood in chronic smokers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2010.06.008

Age-dependent depression in circulating endothelial progenitor cells in patients undergoing coronary artery bypass grafting

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2010.06.008

Circulating CD34-positive cells provide an index of cerebrovascular function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2010.06.008

Simvastatin versus ezetimibe: pleiotropic and lipid-lowering effects on endothelial function in humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2010.06.008

Stimulation of endothelial progenitor cells: a new putative therapeutic effect of angiotensin II receptor antagonists

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2010.06.008

Improvement in endothelial progenitor cells from peripheral blood by ramipril therapy in patients with stable coronary artery disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2010.06.008

PPARgamma-agonist rosiglitazone increases number and migratory activity of cultured endothelial progenitor cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2010.06.008

Endothelial Progenitor Cell Dysfunction: A Novel Concept in the Pathogenesis of Vascular Complications of Type 1 Diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2010.06.008

Human endothelial progenitor cells from type II diabetics exhibit impaired proliferation, adhesion, and incorporation into vascular structures

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2010.06.008

Number and activity of endothelial progenitor cells from peripheral blood in patients with hypercholesterolaemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2010.06.008

Effects of homocysteine on number and activity of endothelial progenitor cells from peripheral blood

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2010.06.008

Circulating endothelial progenitor cells in patients with unstable angina: association with systemic inflammation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2010.06.008

Circulating endothelial progenitor cells and clinical outcome in patients with congestive heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2010.06.008

Profoundly reduced neovascularization capacity of bone marrow mononuclear cells derived from patients with chronic ischemic heart disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2010.06.008

Circulating endothelial progenitor cells predict coronary artery disease severity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2010.06.008

Endothelial progenitor cells are decreased in blood of cardiac allograft patients with vasculopathy and endothelial cells of noncardiac origin are enriched in transplant atherosclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2010.06.008

Insulin stimulates the clonogenic potential of angiogenic endothelial progenitor cells by IGF-1 receptor-dependent signaling

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2010.06.008

Circulating endothelial progenitor cells, vascular function, and cardiovascular risk

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2010.06.008

HMG-CoA reductase inhibitors (statins) increase endothelial progenitor cells via the PI 3-kinase/Akt pathway

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2010.06.008

HMG-CoA reductase inhibitors reduce senescence and increase proliferation of endothelial progenitor cells via regulation of cell cycle regulatory genes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2010.06.008

Endothelial progenitor cell senescence is accelerated in both experimental hypertensive rats and patients with essential hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2010.06.008

Impaired progenitor cell activity in age-related endothelial dysfunction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2010.06.008

Circulating endothelial progenitor cells from healthy smokers exhibit impaired functional activities.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2010.06.008

Statin therapy accelerates reendothelialization: a novel effect involving mobilization and incorporation of bone marrow-derived endothelial progenitor cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2010.06.008

Proliferation, differentiation, and tube formation by endothelial progenitor cells in response to shear stress

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2010.06.008

Angiotensin II accelerates endothelial progenitor cell senescence through induction of oxidative stress

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2010.06.008

The PPAR-gamma agonist pioglitazone increases neoangiogenesis and prevents apoptosis of endothelial progenitor cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2010.06.008

Statins enhance migratory capacity by upregulation of the telomere repeat-binding factor TRF2 in endothelial progenitor cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2010.06.008

Repair of infarcted myocardium by autologous intracoronary mononuclear bone marrow cell transplantation in humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2010.06.008

Intracoronary injection of mononuclear bone marrow cells in acute myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2010.06.008

Anterior myocardial infarction with acute percutaneous coronary intervention and intracoronary injection of autologous mononuclear bone marrow cells: safety, clinical outcome, and serial changes in left ventricular function during 12-months' follow-

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2010.06.008

Long-term results after intracoronary injection of autologous mononuclear bone marrow cells in acute myocardial infarction: the ASTAMI randomised, controlled study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2010.06.008

Intracoronary Bone Marrow–Derived Progenitor Cells in Acute Myocardial Infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2010.06.008

Improved clinical outcome after intracoronary administration of bone-marrow-derived progenitor cells in acute myocardial infarction: final 1-year results of the REPAIR-AMI trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2010.06.008

Clinical outcome 2 years after intracoronary administration of bone marrow-derived progenitor cells in acute myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2010.06.008

Intracoronary autologous bone-marrow cell transfer after myocardial infarction: the BOOST randomised controlled clinical trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2010.06.008

Intracoronary bone marrow cell transfer after myocardial infarction: eighteen months' follow-up data from the randomized, controlled BOOST (BOne marrOw transfer to enhance ST-elevation infarct regeneration) trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2010.06.008

Autologous bone marrow-derived stem-cell transfer in patients with ST-segment elevation myocardial infarction: double-blind, randomised controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2010.06.008

Three-, 6-, and 12-month results of autologous transplantation of mononuclear bone marrow cells in patients with acute myocardial infarction.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2010.06.008

Efficacy of emergent transcatheter transplantation of stem cells for treatment of acute myocardial infarction (TCT-STAMI).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2010.06.008

The BALANCE Study: clinical benefit and long-term outcome after intracoronary autologous bone marrow cell transplantation in patients with acute myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2010.06.008

Experimental and clinical regenerative capability of human bone marrow cells after myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2010.06.008

Autologous bone marrow mononuclear cell transplantation in patients undergoing coronary artery bypass grafting.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2010.06.008

Autologous bone-marrow stem-cell transplantation for myocardial regeneration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2010.06.008

Intramyocardial delivery of CD133+ bone marrow cells and coronary artery bypass grafting for chronic ischemic heart disease: safety and efficacy studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2010.06.008

Safety analysis and improved cardiac function following local autologous transplantation of CD133(+) enriched bone marrow cells after myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2010.06.008

The clinical study of autologous peripheral blood stem cell transplantation by intracoronary infusion in patients with acute myocardial infarction (AMI)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2010.06.008

Intracoronary transplantation of non-expanded peripheral blood-derived mononuclear cells promotes improvement of cardiac function in patients with acute myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2010.06.008

Combined delivery approach of bone marrow mononuclear stem cells early and late after myocardial infarction: the MYSTAR prospective, randomized study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2010.06.008

HMG-CoA reductase inhibitor mobilizes bone marrow--derived endothelial progenitor cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2010.06.008

Essential role of endothelial nitric oxide synthase for mobilization of stem and progenitor cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2010.06.008

Ex vivo pretreatment of bone marrow mononuclear cells with endothelial NO synthase enhancer AVE9488 enhances their functional activity for cell therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2010.06.008

Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2010.06.008

Regeneration of ischemic cardiac muscle and vascular endothelium by adult stem cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2010.06.008

Transdifferentiation of Human Peripheral Blood CD34 + -Enriched Cell Population Into Cardiomyocytes, Endothelial Cells, and Smooth Muscle Cells In Vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2010.06.008

Dose-dependent contribution of CD34-positive cell transplantation to concurrent vasculogenesis and cardiomyogenesis for functional regenerative recovery after myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2010.06.008

Therapeutic potential of ex vivo expanded endothelial progenitor cells for myocardial ischemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2010.06.008

Neovascularization of ischemic myocardium by human bone-marrow-derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2010.06.008

Bone marrow cells regenerate infarcted myocardium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2010.06.008

Transdifferentiation of Blood-Derived Human Adult Endothelial Progenitor Cells Into Functionally Active Cardiomyocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2010.06.008

Haematopoietic stem cells adopt mature haematopoietic fates in ischaemic myocardium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2010.06.008

Haematopoietic stem cells do not transdifferentiate into cardiac myocytes in myocardial infarcts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2010.06.008

Bone marrow-derived hematopoietic cells generate cardiomyocytes at a low frequency through cell fusion, but not transdifferentiation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2010.06.008

Transendocardial autologous bone marrow mononuclear cell injection in ischemic heart failure: postmortem anatomicopathologic and immunohistochemical findings.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2010.06.008

Soluble factors released by endothelial progenitor cells promote migration of endothelial cells and cardiac resident progenitor cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2010.06.008

Endothelial progenitor cells are rapidly recruited to myocardium and mediate protective effect of ischemic preconditioning via "imported" nitric oxide synthase activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2010.06.008

Mobilized bone marrow progenitor cells serve as donors of cytoprotective genes for cardiac repair

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2010.06.008

Evaluation of mobilized peripheral blood CD34(+) cells from patients with severe coronary artery disease as a source of endothelial progenitor cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2010.06.008

Constitutive human telomerase reverse transcriptase expression enhances regenerative properties of endothelial progenitor cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2010.06.008

The dying stem cell hypothesis: immune modulation as a novel mechanism for progenitor cell therapy in cardiac muscle

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2010.06.008

Transplantation of Progenitor Cells and Regeneration Enhancement in Acute Myocardial Infarction (TOPCARE-AMI)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2010.06.008

Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction: final one-year results of the TOPCARE-AMI Trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2010.06.008

Angiogenesis in ischaemic myocardium by intramyocardial autologous bone marrow mononuclear cell implantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2010.06.008

Transendocardial, autologous bone marrow cell transplantation for severe, chronic ischemic heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2010.06.008

Stem cell therapy in acute myocardial infarction: a review of clinical trials

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2010.06.008

Intracoronary infusion of bone marrow-derived mononuclear cells abrogates adverse left ventricular remodelling post-acute myocardial infarction: insights from the reinfusion of enriched progenitor cells and infarct remodelling in acute myocardial in

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2010.06.008

Restoration of microvascular function in the infarct-related artery by intracoronary transplantation of bone marrow progenitor cells in patients with acute myocardial infarction: the Doppler Substudy of the Reinfusion of Enriched Progenitor Cells an

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2010.06.008

Intracoronary bone marrow cell transfer after myocardial infarction: 5-year follow-up from the randomized-controlled BOOST trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2010.06.008

Impact of intracoronary cell therapy on left ventricular function in the setting of acute myocardial infarction: a collaborative systematic review and meta-analysis of controlled clinical trials.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2010.06.008

Autologous bone marrow stem cells to treat acute myocardial infarction: a systematic review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2010.06.008

Adult bone marrow-derived cells for cardiac repair: a systematic review and meta-analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2010.06.008

Transendocardial delivery of autologous bone marrow enhances collateral perfusion and regional function in pigs with chronic experimental myocardial ischemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2010.06.008

Implantation of bone marrow stem cells reduces the infarction and fibrosis in ischemic mouse heart

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2010.06.008

Improved exercise capacity and ischemia 6 and 12 months after transendocardial injection of autologous bone marrow mononuclear cells for ischemic cardiomyopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2010.06.008

Prospective randomized trial of direct endomyocardial implantation of bone marrow cells for treatment of severe coronary artery diseases (PROTECT-CAD trial).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2010.06.008

Recovery of regional but not global contractile function by the direct intramyocardial autologous bone marrow transplantation: results from a randomized controlled clinical trial.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2010.06.008

Intramyocardial bone marrow cell injection for chronic myocardial ischemia: a randomized controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2010.06.008

Regeneration of human infarcted heart muscle by intracoronary autologous bone marrow cell transplantation in chronic coronary artery disease: the IACT Study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2010.06.008

Transcoronary transplantation of progenitor cells after myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2010.06.008

Intramyocardial transplantation of autologous CD34+ stem cells for intractable angina: a phase I/IIa double-blind, randomized controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2010.06.008

A pilot trial to assess potential effects of selective intracoronary bone marrow-derived progenitor cell infusion in patients with nonischemic dilated cardiomyopathy: final 1-year results of the transplantation of progenitor cells and functional reg

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2010.06.008

Incidence and short-term prognosis of late sustained ventricular tachycardia after myocardial infarction: results of the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico (GISSI-3) Data Base

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2010.06.008

Janus phenomenon: the interrelated tradeoffs inherent in therapies designed to enhance collateral formation and those designed to inhibit atherogenesis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2010.06.008

Intracoronary delivery of hematopoietic bone marrow stem cells and luminal loss of the infarct-related artery in patients with recent myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2010.06.008

Effects of intracoronary infusion of peripheral blood stem-cells mobilised with granulocyte-colony stimulating factor on left ventricular systolic function and restenosis after coronary stenting in myocardial infarction: the MAGIC cell randomised cl

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2010.06.008

The effect of stem cell mobilization by granulocyte-colony stimulating factor on neointimal hyperplasia and endothelial healing after vascular injury with bare-metal versus paclitaxel-eluting stents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2010.06.008

Timing of intracoronary bone-marrow-derived stem cell transplantation after ST-elevation myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2010.06.008

Rationale and design for TIME: A phase II, randomized, double-blind, placebo-controlled pilot trial evaluating the safety and effect of timing of administration of bone marrow mononuclear cells after acute myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2010.06.008

Monitoring of bone marrow cell homing into the infarcted human myocardium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2010.06.008

CD34-positive cells exhibit increased potency and safety for therapeutic neovascularization after myocardial infarction compared with total mononuclear cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2010.06.008

Intramyocardial transplantation of autologous endothelial progenitor cells for therapeutic neovascularization of myocardial ischemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2010.06.008

Autologous transplantation of peripheral blood stem cells as an effective therapeutic approach for severe arteriosclerosis obliterans of lower extremities

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2010.06.008

Angina pectoris occurring during granulocyte colony-stimulating factor-combined preparatory regimen for autologous peripheral blood stem cell transplantation in a patient with acute myelogenous leukaemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2010.06.008

Acute arterial thrombosis due to platelet aggregation in a patient receiving granulocyte colony-stimulating factor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2010.06.008

Cell isolation procedures matter: a comparison of different isolation protocols of bone marrow mononuclear cells used for cell therapy in patients with acute myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2010.06.008

Bypass versus angioplasty in severe ischaemia of the leg (BASIL): multicentre, randomised controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2010.06.008

ACC/AHA 2005 Practice Guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): a collaborative report from the American Association for Vascular Surgery/Society for Vascul

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2010.06.008

Functional outcome of critical limb ischemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2010.06.008

Therapeutic angiogenesis for patients with limb ischaemia by autologous transplantation of bone-marrow cells: a pilot study and a randomised controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2010.06.008

Randomised comparison of G-CSF-mobilized peripheral blood mononuclear cells versus bone marrow-mononuclear cells for the treatment of patients with lower limb arteriosclerosis obliterans.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2010.06.008

Autologous bone-marrow mononuclear cell implantation improves endothelium-dependent vasodilation in patients with limb ischemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2010.06.008

Autologous bone marrow cell transplantation increases leg perfusion and reduces amputations in patients with advanced critical limb ischemia due to peripheral artery disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2010.06.008

Transplantation of autologous mononuclear bone marrow stem cells in patients with peripheral arterial disease (the TAM-PAD study).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2010.06.008

Autologous transplantation of granulocyte colony-stimulating factor-mobilized peripheral blood mononuclear cells improves critical limb ischemia in diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2010.06.008

Clinical study of therapeutic angiogenesis by autologous peripheral blood stem cell (PBSC) transplantation in 92 patients with critically ischemic limbs.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2010.06.008

Autologous peripheral blood CD133+ cell implantation for limb salvage in patients with critical limb ischemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2010.06.008

Bone marrow-derived mononuclear cell therapy induces distal angiogenesis after local injection in critical leg ischemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2010.06.008

Evidence for cardiomyocyte renewal in humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2010.06.008

10.1016/J.TRSL.2010.06.008

7 January 2021

Identifiers

DOI

1 reference

23 August 2017

1 reference